Tag: special
-
Commentary – New Models Needed for Antibiotic Resistance
Many parts of a new model for fighting antibiotic resistance are in development, and the pieces still need to be assembled, but the outline of a precision-medicine rather than mass-produced drug model is beginning to emerge.
-
FDA Chief Calls Teen Vaping an “Epidemic”
The commissioner of the Food and Drug Administration warned that the sharp rise in teen electronic cigarette use is an epidemic threatening the public health.
-
Insulin Delivered by Capsule, That’s the Good News
Before we start celebrating the end of injections, we need to deal with a more basic problem facing people with diabetes, namely the rapidly rising cost of insulin.
-
Book Review – The Fifth Risk
Michael Lewis describes in a gripping narrative some of those critical life-protecting functions the federal government performs in his new book The Fifth Risk.
-
Personalized Breast Cancer Trial Advances 7 Drugs
A clinical trial with a design that allows for changes in its processes to meet the needs of individual patients says its results helped advance 7 new drugs for breast cancer into review by FDA.
-
You Call That a Drug Pricing Policy?
Although he called it, “the most sweeping action in history to lower the price of prescription drugs for the American people,” the plan was anything but that.
-
Drug Price Report Calls for Govt Negotiation, More Generics
A panel convened by the National Academies calls for the federal government to use its buying power to negotiate better drug prices for consumers.
-
Here’s What a Real Opioid Emergency Looks Like
Let’s be clear — the limited steps ordered by the president to reduce the numbers of people addicted to opioids don’t look anything like a response to an emergency.
-
Flashback: Drug Pricing Reform Even Big Pharma Might Like
Science & Enterprise is taking a break From 2 to 13 October. Until then, we will re-run some of our recent special reports. Our regular posts will return on 16 October. 2 May 2016. At a press event in Washington, D.C. last week, Representative Lloyd Doggett of Texas, a champion of lower prescription drug prices,…
-
Immigration Crackdown “a Disaster” for U.S. Science
A panel of research executives from American universities said the current hostility to immigration in the U.S. is causing fear among many researchers and could have a serious impact on science.